However, another study that explored key m6A-related enzymes via combined analysis of data from the ONCOMINE and The Cancer Genome Atlas databases with 36 pairs of breast cancer and adjacent non-cancerous tissues, revealed that the expression of all m6A methylases, including METTL3, was reduced in breast cancer. The gene discussed is METTL3; the disease is breast carcinoma.